Cargando…
Short- and long-term outcome of allogeneic stem cell transplantation in infants: A single-center experience over 20 years
INTRODUCTION: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a treatment method for a wide range of malignant and non-malignant diseases. Infants constitute a distinct patient group, especially due to their organ immaturity and differences in drug metabolism. The present paper aim...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441786/ https://www.ncbi.nlm.nih.gov/pubmed/36071886 http://dx.doi.org/10.3389/fped.2022.956108 |
_version_ | 1784782662793166848 |
---|---|
author | Miśkiewicz-Bujna, Justyna Miśkiewicz-Migoń, Izabella Szmit, Zofia Przystupski, Dawid Rosa, Monika Król, Anna Kałwak, Krzysztof Ussowicz, Marek Gorczyńska, Ewa |
author_facet | Miśkiewicz-Bujna, Justyna Miśkiewicz-Migoń, Izabella Szmit, Zofia Przystupski, Dawid Rosa, Monika Król, Anna Kałwak, Krzysztof Ussowicz, Marek Gorczyńska, Ewa |
author_sort | Miśkiewicz-Bujna, Justyna |
collection | PubMed |
description | INTRODUCTION: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a treatment method for a wide range of malignant and non-malignant diseases. Infants constitute a distinct patient group, especially due to their organ immaturity and differences in drug metabolism. The present paper aims to analyse the short- and long-term outcomes after allo-HSCT in infants. MATERIAL AND METHODS: In the study period, 67 patients under 12 months of age underwent allo-HSCT. This study is a retrospective analysis of patient medical records, in the form of paper and electronic documentation. RESULTS: The probability of 5-year OS was 69% and 72% in patients with malignant and non-malignant diseases, respectively. The allo-HSCT from a matched donor was associated with improved OS in comparison to haploidentical donor (0.8 vs. 0.58%, p = 0.0425). The overall incidence of acute graft-vs.-host disease (aGVHD) was 59.3%, and grade III–IV aGVHD was diagnosed in 23% of patients. The 100-day non-relapse mortality (NRM) in the study cohort was 17.9%, while the 5-year NRM was 26.9%. Among the causes of NRM, infections occurred in 83.3% of patients, and aGVHD in 16.3% of individuals. Twenty-two children (32.8%) required hospitalization in the pediatric intensive care unit (PICU). The median length of PICU hospitalization was 6 days (range 1 to 12 days). Late sequelae diagnosed during post-transplant surveillance included ocular disorders in 26.8% of patients, cardiac complications in 4.4%, as well as endocrinopathy with short stature (<3rd percentile) in 37.2% and overt hypothyroidism in 35.4%. In the long-term perspective, 83.3% of survivors were able to attend a regular school. CONCLUSIONS: Improvements in unrelated donor availability, and better supportive care resulted in better outcomes. Management of infant allo-HSCT recipients requires the formation of multi-disciplinary specialist teams. In addition, the role of parental empowerment must be acknowledged; for example, in speech therapy and rehabilitation. |
format | Online Article Text |
id | pubmed-9441786 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94417862022-09-06 Short- and long-term outcome of allogeneic stem cell transplantation in infants: A single-center experience over 20 years Miśkiewicz-Bujna, Justyna Miśkiewicz-Migoń, Izabella Szmit, Zofia Przystupski, Dawid Rosa, Monika Król, Anna Kałwak, Krzysztof Ussowicz, Marek Gorczyńska, Ewa Front Pediatr Pediatrics INTRODUCTION: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a treatment method for a wide range of malignant and non-malignant diseases. Infants constitute a distinct patient group, especially due to their organ immaturity and differences in drug metabolism. The present paper aims to analyse the short- and long-term outcomes after allo-HSCT in infants. MATERIAL AND METHODS: In the study period, 67 patients under 12 months of age underwent allo-HSCT. This study is a retrospective analysis of patient medical records, in the form of paper and electronic documentation. RESULTS: The probability of 5-year OS was 69% and 72% in patients with malignant and non-malignant diseases, respectively. The allo-HSCT from a matched donor was associated with improved OS in comparison to haploidentical donor (0.8 vs. 0.58%, p = 0.0425). The overall incidence of acute graft-vs.-host disease (aGVHD) was 59.3%, and grade III–IV aGVHD was diagnosed in 23% of patients. The 100-day non-relapse mortality (NRM) in the study cohort was 17.9%, while the 5-year NRM was 26.9%. Among the causes of NRM, infections occurred in 83.3% of patients, and aGVHD in 16.3% of individuals. Twenty-two children (32.8%) required hospitalization in the pediatric intensive care unit (PICU). The median length of PICU hospitalization was 6 days (range 1 to 12 days). Late sequelae diagnosed during post-transplant surveillance included ocular disorders in 26.8% of patients, cardiac complications in 4.4%, as well as endocrinopathy with short stature (<3rd percentile) in 37.2% and overt hypothyroidism in 35.4%. In the long-term perspective, 83.3% of survivors were able to attend a regular school. CONCLUSIONS: Improvements in unrelated donor availability, and better supportive care resulted in better outcomes. Management of infant allo-HSCT recipients requires the formation of multi-disciplinary specialist teams. In addition, the role of parental empowerment must be acknowledged; for example, in speech therapy and rehabilitation. Frontiers Media S.A. 2022-08-22 /pmc/articles/PMC9441786/ /pubmed/36071886 http://dx.doi.org/10.3389/fped.2022.956108 Text en Copyright © 2022 Miśkiewicz-Bujna, Miśkiewicz-Migoń, Szmit, Przystupski, Rosa, Król, Kałwak, Ussowicz and Gorczyńska. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Miśkiewicz-Bujna, Justyna Miśkiewicz-Migoń, Izabella Szmit, Zofia Przystupski, Dawid Rosa, Monika Król, Anna Kałwak, Krzysztof Ussowicz, Marek Gorczyńska, Ewa Short- and long-term outcome of allogeneic stem cell transplantation in infants: A single-center experience over 20 years |
title | Short- and long-term outcome of allogeneic stem cell transplantation in infants: A single-center experience over 20 years |
title_full | Short- and long-term outcome of allogeneic stem cell transplantation in infants: A single-center experience over 20 years |
title_fullStr | Short- and long-term outcome of allogeneic stem cell transplantation in infants: A single-center experience over 20 years |
title_full_unstemmed | Short- and long-term outcome of allogeneic stem cell transplantation in infants: A single-center experience over 20 years |
title_short | Short- and long-term outcome of allogeneic stem cell transplantation in infants: A single-center experience over 20 years |
title_sort | short- and long-term outcome of allogeneic stem cell transplantation in infants: a single-center experience over 20 years |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441786/ https://www.ncbi.nlm.nih.gov/pubmed/36071886 http://dx.doi.org/10.3389/fped.2022.956108 |
work_keys_str_mv | AT miskiewiczbujnajustyna shortandlongtermoutcomeofallogeneicstemcelltransplantationininfantsasinglecenterexperienceover20years AT miskiewiczmigonizabella shortandlongtermoutcomeofallogeneicstemcelltransplantationininfantsasinglecenterexperienceover20years AT szmitzofia shortandlongtermoutcomeofallogeneicstemcelltransplantationininfantsasinglecenterexperienceover20years AT przystupskidawid shortandlongtermoutcomeofallogeneicstemcelltransplantationininfantsasinglecenterexperienceover20years AT rosamonika shortandlongtermoutcomeofallogeneicstemcelltransplantationininfantsasinglecenterexperienceover20years AT krolanna shortandlongtermoutcomeofallogeneicstemcelltransplantationininfantsasinglecenterexperienceover20years AT kałwakkrzysztof shortandlongtermoutcomeofallogeneicstemcelltransplantationininfantsasinglecenterexperienceover20years AT ussowiczmarek shortandlongtermoutcomeofallogeneicstemcelltransplantationininfantsasinglecenterexperienceover20years AT gorczynskaewa shortandlongtermoutcomeofallogeneicstemcelltransplantationininfantsasinglecenterexperienceover20years |